Viera Kristová, Martin Wawruch
Usage of psychotropic drugs in pregnancy represents not only medical but also ethical problem. From a reason that pregnant women may not be the objective for clinical studies, there exist insufficient evidence-based data about effects of these drugs on the fetus. The present paper offers available information from the literature about possible risks of most frequently used psychotropic drugs in pregnancy: antidepressants, anxiolytics, hypnotics and antipsychotic drugs. Classification of single drugs in relation to their risk according to FDA is introduced on the base of which the doctor obtains information about likely adverse effects on the fetus. Though most of drugs are relatively safe, there exists certain risk for the fetus which has to be known to doctor to inform the pregnant women about risk and benefit of the treatment.